Patents by Inventor Shiming Ye

Shiming Ye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20220119542
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: December 30, 2021
    Publication date: April 21, 2022
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20210277137
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: May 21, 2021
    Publication date: September 9, 2021
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • ANTI-CD40 ANTIBODY AND THEIR USES
    Publication number: 20210024642
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: October 16, 2020
    Publication date: January 28, 2021
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • Anti-CD40 antibody
    Patent number: 10844131
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: November 24, 2020
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • ANTI-CD25 ANTIBODIES AND THEIR USES
    Publication number: 20200308290
    Abstract: The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.
    Type: Application
    Filed: June 11, 2020
    Publication date: October 1, 2020
    Inventors: Yoshiko AKAMATSU, Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • Anti-CD40 antibodies
    Patent number: 10597460
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 24, 2020
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • ANTI-CD40 ANTIBODIES
    Publication number: 20200040090
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: October 21, 2019
    Publication date: February 6, 2020
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20200010558
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: September 3, 2019
    Publication date: January 9, 2020
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • Anti-CD40 antibodies
    Patent number: 10519243
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: December 31, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • Nucleic acid molecules encoding anti-CD40 antibodies
    Patent number: 10400041
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: September 3, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • Bispecific binding proteins that bind CD40 and mesothelin
    Patent number: 10233258
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: March 19, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko Akamatsu, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20190071509
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: July 16, 2018
    Publication date: March 7, 2019
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • FC VARIANTS
    Publication number: 20180251565
    Abstract: The present disclosure relates to polypeptide variants having modified Fc domains with altered affinity to Fc receptors.
    Type: Application
    Filed: February 22, 2018
    Publication date: September 6, 2018
    Inventors: Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • Anti-CD40 antibodies
    Patent number: 10023645
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: July 17, 2018
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Diane Sau Mun Cohen, Diane Hollenbaugh, Shiming Ye
  • BISPECIFIC BINDING PROTEINS
    Publication number: 20180194862
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 12, 2018
    Inventors: Yoshiko AKAMATSU, Patricia CULP, Charles M. FORSYTH, Ping Y. HUANG, David POWERS, Alan F. WAHL, Shiming YE
  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20180186889
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: February 21, 2018
    Publication date: July 5, 2018
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming YE
  • ANTI-CD40 ANTIBODIES AND THEIR USES
    Publication number: 20170342159
    Abstract: The present disclosure provides novel anti-CD40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Diane Sau Mun COHEN, Diane HOLLENBAUGH, Shiming Ye
  • BISPECIFIC BINDING PROTEINS
    Publication number: 20170342169
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Yoshiko AKAMATSU, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • ANTI-CD25 ANTIBODIES AND THEIR USES
    Publication number: 20170233481
    Abstract: The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.
    Type: Application
    Filed: May 3, 2017
    Publication date: August 17, 2017
    Applicant: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko AKAMATSU, Fiona A. HARDING, Paul R. HINTON, Olivia Jennifer RAZO, Mengli XIONG, Shiming YE
  • ANTI-CD25 ANTIBODIES AND THEIR USES
    Publication number: 20150010539
    Abstract: The present disclosure relates to antibodies directed to CD25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 8, 2015
    Applicant: AbbVie Biotherapeutics Inc.
    Inventors: YOSHIKO AKAMATSU, FIONA A. HARDING, PAUL R. HINTON, MENGLI XIONG, OLIVIA JENNIFER RAZO, SHIMING YE